Synthesis of some pyrrolo[2,3- (2) Talekar, Ratnakar R a Wightman, Richard H a a HERIOT WATT UNIVERSITY (United Kingdom)

Nucleosides and Nucleotides

Volumn 16, Issue 4, 1997, Pages 495-505

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; PYRROLO[2,3]PYRIMIDINE ISODIDEOXYNUCLEOSIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; STEREOCHEMISTRY;

EID: 0030975124     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708001366     Document Type: Article

References (24)

1. Lambert, J.S.; Seiglin, M.; Reichman, R.C.; Plank, C.S.; Dolin, R. New Engl. J. Med., 1990,332,1333.
2. Mitsuya, H.; Broder, S. Proc. Natl. Acad. Sci. USA. 1986,53,1911.
3. Marquez, V.E.; Tseng, C.K.-H.; Kelley, J.A.; Mitsuya, H.; Broder, S.; Roth, J.S.; Driscoll.J.S. Biochem. Pharmacol, 1987,36,2719.
4. Huryn, D.M.; Sluboski, B.C.; Tarn, S.Y.; Todaro, L.J.; Weigele, M. Tetrahedron Lett., 1989,30, 6259;
5. Huryn, D.M.; Sluboski, B.C.; Tarn, S.Y.; Weigele, M.; Sim, I., Anderson, B.D.; Mitsuya, H.; Broder, S. J. Med. Chem., 1992,35,2347.
6. Jones, M.F.; Noble, S.A.; Robertson, C.A.; Storer, R.; Highcock, R.M.; Lamont, R.B. J. Chem. Soc., Perkin Trans, l, 1992,1437.
7. Kim, H.O.; Schinazi, R.F.; Shanmuganathan, K.; Jeong, L.S.; Beach, J.W.; Nampalli, S.; Cannon, D.L.; Chu, C.K. J. Med. Chem., 1993,36, 519, and refs. therein.
8. Jeong, L.S.; Schinazi, R.F.; Beach, J.W.; Nampalli, S.; Shanmuganathan, K.; Alves, A.J.; McMillan, A.; Chu, C.K.; Mathis, R. J. Med. Chem., 1993,36, 182, and refs. therein.
9. Bolon, P.J.; Seils, T.B.; Nuesca, Z.M.; Purdy, D.F.; Nair, V. Tetrahedron, 1994, 50,7747;
10. Nair, V.; St. Clair, M.H.; Reardon, J.E.; Krasny, H.C.; Hazen, R.J.; Paff, M.T.; Boone, L.R.; Tisdale, M.; Najera, L; Dornsife, R.E.; Averett, D.R.; Borrotoesoda, K.; Yale, J.L.; Zimmerman, T.P.; Rideout, J.L. Antimicrob. Agents Chemother., 1995,39,1993.
11. Kakefuda, A.; Shuto, S.; Nagahata, T.; Seki, J.; Sasaki, T.; Matsuda, A. Tetrahedron, 1994,50, 10167.
12. Purdy, D.F.; Zintek, L.B.; Nair, V. Nucleosides Nucleotides, 1994,73,109.
13. (a) Siddiqi, S.M.; Chen X.; Schneller, S.W. Bioorg. Med. Chem. Lett., 1992,2, 1279;
14. (b) Schneller, S.W.; Chen, X.; Siddiqi, S.M. Carbocyclic 7-Deazaguanosine Nucleosides as Antiviral Agents. In Nucleosides and Nucleotides äs Antitumour and Antiviral Agents; Chu, C.K.; Baker D.C. Eds.; Plenum Press: New York, 1993; pp 141-158;
15. Legraverend, M.; Ngono-Tekam, R.-M.N.; Bisagni, E.; Zerial, A. J. Med. Chem., 1985,28, 1477;
16. Saxena, N.K.; Hagenow, B.M.; Genzlinger, G.; Turk, S.R.; Drach, J.C.; L.B. Townsend, L.B. J. Med. Chem., 1988, 37,1501;
17. (e) Seela, F.; Muth, H.-P.; Röling, A. Helv. Chim. Acta, 1991,74,554.
18. Murray, D.H.; Prokop, M. J. Pharm. Sci., 1965,54,1468.
19. 1,2-0-Isopropylidene-cc-D-xylofuranose (Moravková, J.; Capková, J.; Stanek, J. Carbohydr. Res., 1994,263, 61) was converted to the 5-0-acetyl derivative of 10 as reported
20. (De Bernardo, S.; Tengi, J.P.; Sasso, G.J.; Weigele, M. J. Org. Chem., 1985,50, 3457), followed by deacetylation.
21. Cristalli, G.; Franchetti, P.; Grifantini, M.; Vittori, S.; Lupidi, G.; Riva, F.; Bordoni, T.; Geroni, C.; Verini, M.A. J. Med. Chem., 1988,37, 390;
22. Montgomery, J.A.; Hewson, K. J. Med. Chem., 1967,10, 665. In our work, oxidative cleavage of 5-allyl-4,6-dichloropyrimidine was carried out using NalCXj and OsO4 (see réf. lia), and the diethyl acetal was prepared using NïLiCl in dry ethanol (seeréf. lie).
23. Navarre, N.; Preston, P.N.; Tsytovich, A.V.; Wightman, R.H. J. Chem. Res., 1996, (S) 444, (M) 2560.
24. The 8-aza-analogue of (R,/?)-iso-ddA is, as its triphosphate, an active inhibitor of HIV-1 RT; Franchetti, P.; Cappellacci, L.; Grifantini, M.; Messini, L.; Abu Sheikha, G.; Loi, A.G.; Tramontano, E.; De Montis, A.; Spiga, M.G.; La Colla, P. J. Med. Chem., 1994,37,3534.